Riskpilot← Back to searchSign inGet full accessBiotarget Engagement Interest Group AB
ABActiveOrg 5590294368Scheeles Väg 1Research and experimental development on natural sciences and engineering · NACE 7210Est. 20150 employees
Revenue 2024
SEK 3,8M
+12% vs 2023
EBITDA margin
99.7%
+16% vs 2023
Equity ratio
67.5%
Financial strength
Net profit 2024
SEK 3M
+16% vs 2023
| Revenue | SEK 3,8M | +12% |
| EBITDA | SEK 3,8M | +16% |
| Net profit | SEK 3M | +16% |
| Total assets | SEK 4,6M | +16% |
| Equity | SEK 3,1M | +11% |
| Employees | 0 | — |
Legal name
Biotarget Engagement Interest Group AB
Org number
5590294368
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
7 oktober 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Företaget ska bedriva forskning och utveckling inom biofysikaliska metoder samt äga och förvalta en patent-portfölj på samma. Företaget skall även sälja biofysikaliska konsult- tjänster till biotech och läkemedelsföretag.
Address
Scheeles Väg 1
Email
michael@pelagobio.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 766 | 1 996 | 2 387 | 3 406 | 3 808 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 737 | 1 973 | 2 373 | 3 284 | 3 796 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 737 | 1 973 | 2 373 | 3 284 | 3 796 |
| Net financials | −1 | −5 | −2 | −6 | 2 |
| Profit before tax | 1 736 | 1 968 | 2 372 | 3 279 | 3 798 |
| Tax | −372 | −406 | −489 | −677 | −782 |
| Net profit | 1 364 | 1 562 | 1 883 | 2 602 | 3 016 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 289 | 2 647 | 3 115 | 3 942 | 4 557 |
| Equity | 1 615 | 1 877 | 2 260 | 2 761 | 3 077 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 674 | 771 | 855 | 1 180 | 1 480 |
| Total debt | 674 | 771 | 855 | 1 180 | 1 480 |
EBITDA margin
99.7%
This company
15.8%
Market median
+531% vs market
20202024
Equity ratio
67.5%
This company
38.2%
Market median
+77% vs market
20202024
Return on equity
98.0%
This company
18.4%
Market median
+433% vs market
20202024
Net profit margin
79.2%
This company
8.1%
Market median
+878% vs market
20202024
Asset turnover
0.84×
This company
1.12×
Market median
+25% vs market
20202024
Debt / equity
0.48×
This company
0.62×
Market median
+23% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
DA Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
| Audit | 2025 | |
MA Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 51% | 51% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Proteinera Holding AB
Biotarget Engagement Interest Group AB Board members of Biotarget Engagement Interest Group AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Daniel Andreas Martinez Molina | Deputy Chief Executive Officer | 0 companies |
| Markus Fredrik Stefan Biesheuvel | Audit | 0 companies |
| Michael Adam Dabrowski | Chief Executive Officer | 0 companies |
| Pär Lennart Nordlund | Chairman | 0 companies |